Skip to main content

Table 1 Demographic and clinical data of patients on continuous veno-venous haemodiafiltration administered ciprofloxacin

From: An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration

 

Sex

Age

Diagnosis

Infective

pathogen

APACHE II score(initial/highest)

CVVHDF Duration(days)

ICU Mortality Outcome

1

M

60

Intestinal Obstruction, Hemicolectomy

Escherichia coli

26

6

Survived

2

F

77

Neutropaenic sepsis

Pseudomonas aeruginosa

27

5

Died

3

F

68

Intestinal obstruction, post-operative sepsis and acute renal failure

Pseudomonas aeruginos a

28

14

Survived

4

M

47

Acute pancreatitis, sepsis

Escherichia Coli

25

14

Survived

5

F

71

ESRD with severe sepsis

Empiric cover

27

8

Died

6

M

57

Hepatic cirrhosis with severe sepsis

Pseudomonas Aeruginosa, Enterococcus faecalis

29

7

Survived

7

M

28

Acute liver failure with severe sepsis

Pseudomonas aeruginosa

30

11

Survived